Page last updated: 2024-08-18

2-aminopyrimidine and African Lymphoma

2-aminopyrimidine has been researched along with African Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Georgieva, SG; Ilyin, YV; Makarova, AA; Pankratova, EV; Portseva, TN; Stepchenko, AG	1

Other Studies

1 other study(ies) available for 2-aminopyrimidine and African Lymphoma

Article	Year
GSK3 Kinase Inhibitor, CHIR, Suppress Transcription of Tissue Specific POU2F1 Isoform in Burkitt Namalwa Lymphoma Cells. Doklady. Biochemistry and biophysics, 2021, Volume: 496, Issue:1 Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Line, Tumor; Glycogen Synthase Kinase 3; Humans; Octamer Transcription Factor-1; Organ Specificity; Promoter Regions, Genetic; Protein Isoforms; Protein Kinase Inhibitors; Pyrimidines; Transcription, Genetic	2021

Article

Year

GSK3 Kinase Inhibitor, CHIR, Suppress Transcription of Tissue Specific POU2F1 Isoform in Burkitt Namalwa Lymphoma Cells.

Doklady. Biochemistry and biophysics, 2021, Volume: 496, Issue:1

Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Line, Tumor; Glycogen Synthase Kinase 3; Humans; Octamer Transcription Factor-1; Organ Specificity; Promoter Regions, Genetic; Protein Isoforms; Protein Kinase Inhibitors; Pyrimidines; Transcription, Genetic

2021